Cerity Partners
FLNA

Cerity Partners’s Filana Therapeutics FLNA Stock Holding History

Cerity Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,364
Closed -$88.4K – 2608
2024
Q4 		$88.4K Buy
35,364
+10
+0% +$176 ﹤0.01% 2346
2024
Q3 		$1.04M Buy
35,354
+88
+0.2% +$2.03K ﹤0.01% 1375
2024
Q2 		$436K Buy
+35,266
New +$743K ﹤0.01% 1613

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cerity Partners's FLNA Position: Q1 2025 in Review

Cerity Partners sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 35,364 shares — an estimated $88.4K sold.

Cerity Partners first reported a position in FLNA in Q2 2024 and held it in 3 quarters. The position peaked at $1.04M in Q3 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Cerity Partners reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Cerity Partners sold 35,364 Filana Therapeutics shares in Q1 2025, an estimated $88.4K.
  • Cerity Partners first reported a position in Filana Therapeutics in Q2 2024 and held it in 3 quarters.
  • Cerity Partners's Filana Therapeutics position peaked at $1.04M in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Cerity Partners's 13F filing for Q1 2025, filed 30 Apr 2025.